Connect Biopharma Completes $115 Million Series C Financing to Advance Ongoing Clinical Trials in Atopic Dermatitis and Ulcerative Colitis and Initiate Additional Clinical Programs

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2YwHpk8
via IFTTT